Vanderbilt Health announced an October 8 hearing-loss study combining clinical hearing-test information with genetic records from its BioVU biobank.
The announcement names audiologist Andie DeFreese as a co-first author and otolaryngologist Taha Jan as the corresponding author.
Vanderbilt says the study appeared in JAMA Otolaryngology–Head & Neck Surgery on October 8. The announcement describes research into sensorineural hearing loss; it does not announce a clinical genetic test or treatment.
The announcement identifies a Vanderbilt hearing-loss project, its data resources and named study roles. This brief provides those institutional facts and the publication pointer; it does not appraise the paper’s findings or clinical implications.
Go to the source.
Vanderbilt Health · October 8, 2026 research announcement ↗This brief summarizes publicly announced information. It does not establish clinical superiority or recommend a treatment.
